Linked e-resources
Details
Table of Contents
Part 1. Introduction
1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review)
Part 2. Impact of complement on diabetic disease
2. Complement and Complement Regulatory Proteins in Diabetes
Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation
3. Development of adiponectin receptor C terminal fragment bioassays
4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor
5. Cell & biological models for the C terminal fragment of adiponectin receptor
6. C-Terminal fragment of adiponectin receptor clinical correlations
Part 4. Uristatin assay for prediction of renal and other clinical events
7. Uristatin immunoassay usage in glomerular nephritis assessment
8. Acute Response of Uristatin in Surgery
9. Cardiovascular and metabolic syndrome impact on uristatin
10. Uristatin anti-inflammatory cellular signaling
Part 5. Summary
11. Overview of progress in new markers for diabetes inflammation (Literatue Review).
1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review)
Part 2. Impact of complement on diabetic disease
2. Complement and Complement Regulatory Proteins in Diabetes
Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation
3. Development of adiponectin receptor C terminal fragment bioassays
4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor
5. Cell & biological models for the C terminal fragment of adiponectin receptor
6. C-Terminal fragment of adiponectin receptor clinical correlations
Part 4. Uristatin assay for prediction of renal and other clinical events
7. Uristatin immunoassay usage in glomerular nephritis assessment
8. Acute Response of Uristatin in Surgery
9. Cardiovascular and metabolic syndrome impact on uristatin
10. Uristatin anti-inflammatory cellular signaling
Part 5. Summary
11. Overview of progress in new markers for diabetes inflammation (Literatue Review).